Intact Medical is developing a Breast Lesion Excision System that uses radiofrequency (RF) energy in a minimally invasive procedure to withdraw sample breast tissue. The company closed a $4 million equity funding round that it says will benefit its breast biopsy systems. Filings list 11 unnamed investors as participants in the round. Intact is a privately held company founded in 1998 and is based in Framingham, Mass. The company won FDA approval in 2001 to market its technology for biopsy and excision of benign lesions, and the FDA expanded the label in 2005 to include obtaining tissue samples with partial or complete removal of certain imaged or palpable abnormalities.

Total raised

$4M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2013